Tadalafil for erectile dysfunction: outstanding efficacy for 36 hours.
- Author:
Shu-Min DENG
1
Author Information
1. Department of Urology, Beijing Hospital, Beijing 100730, China. dsm20010627@yahoo.com.cn
- Publication Type:Journal Article
- MeSH:
Carbolines;
administration & dosage;
adverse effects;
therapeutic use;
Cyclic Nucleotide Phosphodiesterases, Type 5;
administration & dosage;
adverse effects;
therapeutic use;
Erectile Dysfunction;
drug therapy;
Humans;
Male;
Tadalafil;
Treatment Outcome
- From:National Journal of Andrology
2008;14(9):857-860
- CountryChina
- Language:Chinese
-
Abstract:
Phosphodiesterase type 5 (PDE5) inhibitors are first-line oral medication for erectile dysfunction (ED). Compared with the other two PDE inhibitors (sildenafil and vardenafil), tadalafil is characterized by rapid onset, convenient dosing, excellent efficacy, especially the 36-hour duration of effectiveness deriving from long elimination half-life, allowing for more flexibility to scheduled medication. Higher satisfaction of patients and their partners with tadalafil is mainly due to such psychosocial benefits as decreased time concerns. Tadalafil is well-tolerated, consistent with the principle of safely, effectiveness and convenient dosing and is becoming the favorite choice of ED patients and their partners.
